Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Axsome Therapeutics Inc (AXSM)

  7. Axsome Therapeutics Inc (AXSM) Financials

AXSM

Axsome Therapeutics Inc
61.96
-0.05 (-0.08%)
Upgrade to Real-Time

Axsome Therapeutics Inc. (AXSM) Fundamentals
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.
SHARE INFORMATION
Market Cap$ 2,739,798,903
Shares Outstanding43,516,501
Float35,514,501
Percent Float81.61%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 50,037,106
Latest Fiscal EPS$ -4.59
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions446
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months5,513,096
Institutional Holdings Percent101.0%
Institutional Sold Previous 3 Months4,929,135
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months17,501
Insider Holdings Percent0.5
Insider Sold Previous 3 Months17,501
Insider Shares Owned214,253
TRADING INFO
52 Week High$ 82.00
52 Week Low$ 20.63
52 Week High Change$ 82.81
21 Day Moving Average$ 63.3462
21 Day Extended Moving Average$ 63.5046
50 Day Moving Average$ 65.844
50 Day Extended Moving Average$ 64.9049
200 Day Moving Average$ 55.465
200 Day Extended Moving Average$ 57.6518
10 Day Average Volume1,067,131
20 Day Average Volume1,022,370
30 Day Average Volume972,949
50 Day Average Volume973,043
Alpha0.095384
Beta1.9451
Standard Deviation0.412816
R20.064380
7 Day Price Change$ 1.03
7 Day Percent Change1.66%
21 Day Price Change$ -3.93
21 Day Percent Change-5.88%
30 Day Price Change$ 0.35
30 Day Percent Change0.56%
Month to Date Price Change$ -5.23
Month to Date Percent Change-7.67%
Quarter to Date Price Change$ -14.17
Quarter to Date Percent Change-18.37%
180 Day Price Change$ 10.74
180 Day Percent Change20.57%
200 Day Price Change$ -0.03
200 Day Percent Change-0.05%
Year to Date Price Change$ -14.17
Year to Date Percent Change-18.37%

Axsome Therapeutics Inc. (AXSM) Key Ratios

PROFITABILITY
EBIT Margin-594.1%
EBITDA Margin-579.1%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin89.6%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 50,037,106
Revenue Per Share$ 1.1498
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book69.10
Total Debt To Equity0.90
Int Coverage-24.50
Current Ratio2.50
Leverage Ratio3.10
Quick Ratio2.50
Long Term Debt To Capital0.46
VALUATION MEASURES
PE Ratio-15.00
Enterprise Value$ 2,630,159,188
Price to Sales54.7553
Price to Free Cash-16.10
PE High Last 5 Years-4.50
Price To Book25.00
Price To Cash Flow0.00
PE Low Last 5 Years-17.60
Price to Tangible Book69.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.60
Invoice Turnover1.70
Assets Turnover0.20
Return Assets-90.34
Return on Equity-301.10
Return on Capital-88.54

Axsome Therapeutics Inc. (AXSM) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOHerriot Tabuteau
Emplyoees383
Last AuditUQ
CIK0001579428
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address22 Cortlandt Street
16th Floor
New York, NY 10007
Websitehttps://www.axsome.com
Facsimile+1 212 320-0245
Telephone+1 212 332-3241
Emailmjacobson@axsome.com


Your Recent History
NASDAQ
AXSM
Axsome The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.